Mass vaccination to control epidemic and endemic typhoid fever

Current Topics in Microbiology and Immunology

Volumn 304, Issue , 2006, Pages 231-246

  Levine, M M ^a  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KILLED WHOLE CELL VACCINE; TYPHOID VACCINE; UNCLASSIFIED DRUG; TYPHOID PARATYPHOID VACCINE;

CLINICAL TRIAL; DISEASE CONTROL; DRUG DELIVERY SYSTEM; ENDEMIC DISEASE; EPIDEMIC; HUMAN; MASS IMMUNIZATION; PRIORITY JOURNAL; PROPHYLAXIS; RECOMMENDED DRUG DOSE; REVIEW; SALMONELLA TYPHI; SINGLE DRUG DOSE; TYPHOID FEVER; IMMUNOLOGY;

HUMANS; MASS IMMUNIZATION; TYPHOID FEVER; TYPHOID-PARATYPHOID VACCINES;

EID: 34548701769     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/3-540-36583-4_13     Document Type: Review

References (50)

1. Acharya VI, Lowe CU, Thapa R, Gurubacharya VL, Shrestha MB, Cadoz M, Schulz D, Armand J, Bryla DA, Trollfors B, Cramton T, Schneerson R, Robbins JB (1987) Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report. N Engl J Med 317:1101-1104
2. Arya SC (2000) Salmonella typhi Vi antigen-negative isolates in India and prophylactic typhoid immunization. Natl Med J India 13:220
3. Arya SC (2002) Field effectiveness of Vi polysaccharide typhoid vaccine in the People's Republic of China. J Infect Dis 185:845-846
4. Ashcroft MT, Morrison-Ritchie J, Nicholson CC (1964) Controlled field trial in British Guyana schoolchildren of heat-killed-phenolized and acetone-killed lyophilized typhoid vaccines. Am J Hyg 79:196-206
5. Ashcroft MT, Nicholson CC, Balwant S, Ritchie JM, Sorvan E, William F (1967) A seven-year field trial of two typhoid vaccines in Guiana. Lancet 2:1056-1060
6. Batson HC. 1949. Typhoid fever prophylaxis by active immunization. Pub Health Rep supplement 212:1-34
7. Black RE, Levine MM, Ferreccio C, Clements ML, Lanata C, Rooney J, Germanier R (1990) Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric-coated capsules in a controlled field trial. Chilean Typhoid Committee. Vaccine 8:81-84
8. Bodhidatta L, Taylor DN, Thisyakorn U, Echeverria P (1987) Control of typhoid fever in Bangkok, Thailand, by annualimmunization of school children with parenteral typhoid fever. Rev Infect Dis 9:841-845
9. Bollag U (1980) Practical evaluation of a pilot immunization campaign against typhoid fever in a Cambodian refugee camp. Int J Epidemiol 9:121-122
10. Butler T, Linh NN, Arnold K, Pollack M (1973) Chloramphenicol-resistant typhoid fever in Vietnam associated with R factor. Lancet 2:983-985
11. Cockburn WC (1955) The early history of typhoid vaccination. J Royal Army Medical Corps 101:171-185
12. Ferreccio C, Levine MM, Rodriguez H, Contreras R (1989) Comparative efficacy of two, three, or four doses of Ty21a live oral typhoid vaccine in enteric-coated capsules: a field trial in an endemic area. J Infect Dis 159:766-769
13. Germanier R, Furer E (1975) Isolation and characterization of gal E mutant Ty21a of Salmonella typhi: A candidate strain for a live oral typhoid vaccine. J Infect Dis 141:553-558
14. Gilman RH, Terminel M, Levine MM, Hernandez Mendosa P, Calderone E, Vasquez V, Martinez E, Snyder MJ, Hornick RB (1975) Comparison of trimethoprim-sulfamethoxazole and amoxicillin in therapy of chloramphenicol- resistant and chloramphenicol-sensitive typhoid fever. J Infect Dis 132:630-636
15. Goodall EW (1937) Immunization against typhoid. BMJ 1197
16. Greenwood M, Yule GU. 1915. The statistics of anti-typhoid and anti-cholera inoculations and the interpretation of such statistics in general. Proc Roy Soc Med 8:113-194
17. Gupta A (1994) Multidrug-resistant typhoid fever in children: epidemiology and therapeutic approach. Pediatr Infect Dis 13:124-140
18. Hahn M (1927) Mitteilungen zur Typhusendemie in Hannover. Med Klin 27:1009-1012
19. Hefjec LB, Levina LA, Kuz'minova ML, et al. (1969) A controlled field trial to evaluate the protective capacity of a single dose of acetone-killed agar-grown and heat-killed broth-grown tphoid vaccines. Bull WHO 40:903-907
20. Hejfec LB, Salmin LV, Lejtman MZ, Kuzminova ML, Vasileva AV, Levina LA, Bencianova TG, Pavlova EA, Antonova AA (1966) A controlled field trial and laboratory study of five typhoid vaccines in the USSR. Bull WHO 34:321-339
21. Hornick RB, Greisman SE, Woodward TE, DuPont HL, Dawkins AT, Snyder MJ (1970) Typhoid fever; pathogenesis and immunologic control. N Eng J Med 283:686-691, 739-746
22. Keitel WA, Bond NL, Zahradnik JM, Cramton TA, Robbins JB (1994) Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines. Vaccine 12:195-199
23. Klugman K, Gilbertson IT, Kornhoff HJ, Robbins JB, Schneerson R, Schulz D, Cadoz M, Armand J (1987) Protective activity of Vi polysaccharide vaccine against typhoid fever. Lancet 2:1165-1169
24. Klugman KP, Koornhof HJ, Robbins JB, Le Cam NN (1996) Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization. Vaccine 14:435-438
25. Levine MM, Black RE, Ferreccio C, Clements ML, Lanata C, Sears S, Morris JG, Cisneros L, Germanier R, Chilean TYphoid Commission (1986) Interventions to control endemic typhoid fever: Field studies in Santiago, Chile. In: Washington, D.C.:PAHO Copublication Series No. 1. p. 37-53
26. Levine MM, Black RE, Lanata C, Chilean Typhoid Committee (1982) Precise estimation of the numbers of chronic carriers of Salmonella typhi in Santiago, Chile, an endemic area. J Infect Dis 146:724-726
27. Levine MM, Ferreccio C, Abrego P, Martin OS, Ortiz E, Cryz S (1999) Duration of efficacy of ty21a, attenuated salmonella typhi live oral vaccine. Vaccine 17 Suppl 2:S22-S27
28. Levine MM, Ferreccio C, Black RE, Germanier R, Chilean Typhoid Committee (1987) Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation. Lancet 1:1049-1052
29. Levine MM, Ferreccio C, Black RE, Tacket CO, Germanier R (1989a) Progress in vaccines against typhoid fever. Rev Infect Dis 11 Suppl 3:S552-S567
30. Levine MM, Ferreccio C, Black RE, Tacket CO, Germanier R, Chilean Typhoid Committee (1989b) Progress in vaccines to prevent typhoid fever. Rev Infect Dis 11:S552-S567
31. Levine MM, Ferreccio C, Cryz S, Ortiz E (1990) Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial. Lancet 336:891-894
32. Levine MM, Taylor DN, Ferreccio C (1989c) Typhoid vaccines come of age. Pediatr Infect Dis J 8:374-381
33. Mermin JH, Townes JM, Gerber M, Dolan N, Mintz ED, Tauxe RV (1998) Typhoid fever in the United States, 1985-1994: changing risks of international travel and increasing antimicrobial resistance. Arch Intern Med 158:633-638
34. Mermin JH, Villar R, Carpenter J, Roberts L, Samaridden A, Gasanova L, Lomakina S, Bopp C, Hutwagner L, Mead P, Ross B, Mintz ED (1999) A massive epidemic of multidrug-resistant typhoid fever in Tajikistan associated with consumption of municipal water. J Infect Dis 179:1416-1422
35. Mikhail IA, Haberberger RL, Farid Z, Girgis NI, Woody JN (1989) Antibiotic-multiresistant Salmonella typhi in Egypt. Trans R Soc Trop Med Hyg 83:120
36. Pfeiffer R, Kolle W (1896) Experimentelle Untersuchunger zur Frage der Schutzimpfung des Menschen gegen Typhus abdominalis. Dtsch Med Wocheschr 22:735-737
37. Reisinger EC, Grasmug E, Krejs GJ (1994) Antibody response after vaccination against typhoid fever in Kurdish refugee camp. Lancet 343:918-919
38. Robbins J, Robbins J (1984) Reexamination of the protective role of the capsular polysaccharide Vi antigen of Salmonella typhi. J Infect Dis 150:436-449
39. Rowe B, Ward LR, Threlfall EJ (1997) Multidrug-resistant Salmonella typhi: a worldwide epidemic. Clin Infect Dis 24 Suppl 1:S106-109
40. Siler JF, Dunham GC, Longfellow D, Luippold GF (1941) Immunizationto typhoid fever. [17], pp. 1-276. 1941. Baltimore, Johns Hopkins Press. Am J Hygiene monographic series. Ref Type: Serial (Book,Monograph)
41. Steinberg EB, Bishop R, Haber P, Dempsey AF, Hoekstra RM, Nelson JM, Ackers M, Calugar A, Mintz ED (2004) Typhoid fever in travelers: who should be targeted for prevention? Clin Infect Dis 39:186-191
42. Tarr PE, Kuppens L, Jones TC, Ivanoff B, Aparin PG, Heymann DL (1999) Considerations regarding mass vaccination against typhoid fever as an adjunct to sanitation and public health measures: potential use in an epidemic in Tajikistan. Am J Trop Med Hyg 61:163-170
43. Wang ZG, Zhou WZ, Shi J (1997) [Efficacy and side effects following immunization with Salmonella typhi Vi capsular polysaccharide vaccine]. Zhonghua Liu Xing Bing Xue Za Zhi 18:26-29
44. Williams WC, Bishop EL (1936) The typhoid control program and results of 13 years' work in Williamson County, Tennessee, 1922-35. Pub Health Rep 51:1-27
45. Wolman A, Gorman A (1931) The significance of waterborne typhoid fever outbreaks. Baltimore: Williams & Wilkins
46. Wright AE, Semple D (1897) Remarks on vaccination against typhoid fever. BMJ 1:256-258
47. Yang HH, Kilgore PE, Yang LH, Park JK, Pan YF, Kim Y, Lee YJ, Xu ZY, Clemens JD (2001a) An outbreak of typhoid fever, Xing-An County, People's Republic of China, 1999: estimation of the field effectiveness of Vi polysaccharide typhoid vaccine. J Infect Dis 183:1775-1780
48. Yang HH, Wu CG, Xie GZ, Gu QW, Wang BR, Wang LY, Wang HF, Ding ZS, Yang Y, Tan WS, Wang WY, Wang XC, Qin M, Wang JH, Tang HA, Jiang XM, Li YH, Wang ML, Zhang SL, Li GL (2001b) Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China. Bull WHO 79:625-631
49. Yugoslav Typhoid Commission (1962) A controlled field trial of the effectiveness of phenol and alcohol typhoid vaccines. Bull WHO 26:357-369
50. Yugoslav Typhoid Commission (1964) A controlled field trial of the effectiveness of acetone-dried and inactivated and heat-phenol-inactivated typhoid vaccines in Yugoslavia. Bull WHO 30:623-630